# Ishares Gold Trust: financial statements, quarterly

IAU · NYSE · CIK 1278680 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/iau.md) · [Financials](/companies/iau/financials.md) · [Filings](/companies/iau/filings.md) · [Insiders](/companies/iau/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/iau/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(17.1)](/filings/0001437749-24-033816.md) | [(16.1) d](/filings/0001437749-26-006055.md) | [(16.2)](/filings/0001437749-25-033433.md) | [(17.8)](/filings/0001437749-25-033433.md) | [(18.6)](/filings/0001437749-25-033433.md) | [(20.7) d](/filings/0001437749-26-006055.md) | [(22.8)](/filings/0001437749-26-015532.md) | [(28.6)](/filings/0001437749-25-033433.md) | [(31.8)](/filings/0001437749-25-033433.md) | [(40.8) d](/filings/0001437749-26-006055.md) | [(47.4)](/filings/0001437749-26-015532.md) | not reported |
| Net income | $m | [(556)](/filings/0001437749-24-033816.md) | [2,464 d](/filings/0001437749-26-006055.md) | [1,871](/filings/0001437749-25-033433.md) | [1,426](/filings/0001437749-25-033433.md) | [3,541](/filings/0001437749-25-033433.md) | [(285) d](/filings/0001437749-26-006055.md) | [6,551](/filings/0001437749-26-026002.md) | [2,312](/filings/0001437749-26-026002.md) | [7,943](/filings/0001437749-25-033433.md) | [7,456 d](/filings/0001437749-26-006055.md) | [4,912](/filings/0001437749-26-026002.md) | [(8,986)](/filings/0001437749-26-026002.md) |
| Basic EPS | $ per share | [(0.75)](/filings/0001437749-24-033816.md) | not reported | [2.81](/filings/0001437749-25-015165.md) | [2.20](/filings/0001437749-25-024887.md) | [5.58](/filings/0001437749-25-033433.md) | not reported | [9.53](/filings/0001437749-26-015532.md) | [3.12](/filings/0001437749-26-026002.md) | [10.23](/filings/0001437749-25-033433.md) | not reported | [5.84](/filings/0001437749-26-015532.md) | [(11.00)](/filings/0001437749-26-026002.md) |

- Revenue: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Net income: us-gaap:NetIncomeLoss
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2020 (2020-03-31) | Q2 FY2020 (2020-06-30) | Q3 FY2020 (2020-09-30) | FY2020 (2020-12-31) | Q1 FY2021 (2021-03-31) | Q2 FY2021 (2021-06-30) | Q3 FY2021 (2021-09-30) | FY2021 (2021-12-31) | Q1 FY2022 (2022-03-31) | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | FY2022 (2022-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $ | [0.0](/filings/0001437749-21-010720.md) | [0.0](/filings/0001437749-21-018891.md) | [0.0](/filings/0001437749-21-025052.md) | [0.0](/filings/0001437749-23-004329.md) | [0.0](/filings/0001437749-22-011360.md) | [0.0](/filings/0001437749-22-018860.md) | [0.0](/filings/0001437749-22-025346.md) | [0.0](/filings/0001437749-23-004329.md) | [0.0](/filings/0001437749-22-011360.md) | [0.0](/filings/0001437749-22-018860.md) | [0.0](/filings/0001437749-22-025346.md) | [0.0](/filings/0001437749-23-004329.md) |
| Total assets | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total liabilities | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: not reported
- Total liabilities: not reported
- Shareholders' equity: not reported

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $ | [0.0 d](/filings/0001437749-24-033816.md) | [0.0 d](/filings/0001437749-26-006055.md) | [0.0](/filings/0001437749-25-015165.md) | [0.0 d](/filings/0001437749-25-024887.md) | [0.0 d](/filings/0001437749-25-033433.md) | [0.0 d](/filings/0001437749-26-006055.md) | [0.0](/filings/0001437749-26-015532.md) | [0.0 d](/filings/0001437749-26-026002.md) | [0.0 d](/filings/0001437749-25-033433.md) | [0.0 d](/filings/0001437749-26-006055.md) | [0.0](/filings/0001437749-26-015532.md) | [0.0 d](/filings/0001437749-26-026002.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

Shares outstanding: 788,600,000 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001437749-26-026002.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.